RxDoctor Payments DataLook up a doctor →

Gregory Papa, DO

Family Medicine · New Castle, DENPI 1730242397

Payments from drug & device makers

$66,969in general payments, 2019–2025

Across 1,610 payments — averaging $41.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$33K
  • Biohaven Pharmaceuticals, Inc.$10K
  • Novo Nordisk$4K
  • AstraZeneca$3K
  • Biohaven Pharmaceutical Holding Company Ltd.$3K
  • GSK$2K
  • plus $13K from 43 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)320$32,541
Biohaven Pharmaceuticals, Inc.29$10,309
Novo Nordisk239$3,759
AstraZeneca88$2,909
Biohaven Pharmaceutical Holding Company Ltd.25$2,785
GSK88$1,849
Pfizer144$1,747
Axsome Therapeutics, Inc.85$1,599
Johnson & Johnson51$876
Astellas Pharma US Inc51$773
Jazz Pharmaceuticals Inc.47$756
Boehringer Ingelheim26$616
Alkermes, Inc.36$611
Kowa Pharmaceuticals America, Inc.56$576
Lilly USA, LLC41$543
Corcept Therapeutics22$505
Sanofi-aventis U.S. LLC31$492
Daiichi Sankyo Inc.55$451
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)16$396
Abbott24$322
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC25$286
Merck18$243
Amarin Pharma, Inc.13$224
Neurocrine Biosciences, Inc.5$202
Braeburn Inc.4$179
Takeda Pharmaceuticals U.S.A., Inc.11$166
Dexcom, Inc.3$138
Sunovion Pharmaceuticals Inc.7$122
Novartis7$120
Mylan Specialty L.p.4$103
Amgen6$101
Indivior Inc.4$85
Corium, LLC3$82
Phathom Pharmaceuticals, Inc.3$76
Exact Sciences2$68
Ardelyx, Inc.3$44
Medtronic2$41
Vanda Pharmaceuticals Inc.2$35
E.r. Squibb & Sons, L.L.C.2$35
Ironwood Pharmaceuticals, Inc2$33
Idorsia Pharmaceuticals US Inc2$32
Tactile Systems Technology Inc1$27
Otsuka America Pharmaceutical, Inc.1$24
Almatica Pharma LLC1$17
Evoke Pharma, Inc.1$16
Insulet Corporation1$15
Resmed Corp1$15
Eisai Inc.1$13
Shire North American Group Inc1$12

How this compares

$66,969 in reported general payments places this provider in the 95th percentile of 352 family medicine providers in Delaware.

See all family medicine providers in Delaware →

Medicare billing

Part B allowed, 2024
$109,000
Medicare patients
249
Services billed
1,448

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in New Castle

See the full list for Delaware →

Where these figures come from

Is this you, or does something look wrong? →